Type 1 diabetes: open trials in Belgium

16 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT07222137
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Trial Treatment · Phase 3 · Eli Lilly and Company
Antwerp University Hospital, Antwerpen · Cliniques Universitaries Saint Luc, Bruxelles-Capitale · UZ Brussel, Jette · UZ Leuven, Leuven · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur
Registry updated 2026-11-04
NCT07222332
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Trial Treatment · Phase 3 · Eli Lilly and Company
Hopital Erasme, Anderlecht · Universitair Ziekenhuis Antwerpen, Edegem · Universitair Ziekenhuis Gent, Gent · UZ Brussel, Jette · UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Namur · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe · Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur, Yvoir
Registry updated 2026-11-04
2023-507348-35-00
Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A
Trial Treatment · Phase 4 · Klinikum rechts der Isar der TU Muenchen AöR
UZ Leuven, Leuven
Registry updated 2026-10-22
NCT07088068
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Trial Treatment · Phase 3 · Sanofi
Brussels · Brussels · Edegem · Jette · Leuven · Leuven · Liège · Namur
Registry updated 2026-10-13
NCT07187531
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Trial Treatment · Phase 2 · SAb Biotherapeutics, Inc.
UZ Brussel, Jette · UZ Leuven, Leuven · CHC MontLégia, Liège
Registry updated 2026-10-13
NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Trial Treatment · Phase 3 · Novo Nordisk A/S
Anima, Alken · Kormont, Kluisbergen · Centre hospitalier universitaire de Tivoli Institut medical des Mutualites socialistes, La Louviere · Meclinas, Mechelen · Algemeen Ziekenhuis Delta, Roeselare · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-09-30
NCT07227805
Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
Trial Treatment · Medtronic MiniMed, Inc.
Universitair Ziekenhuis Antwerpen, Antwerp · Cliniques Universitaires de Bruxelles Hopital Erasme, Brussels · UZ Leuven, Leuven
Registry updated 2026-09-21
NCT07457580
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Research · Sanofi
Leuven
Registry updated 2026-08-26
NCT07118098
INNODIA Family & Friends Early-Stage T1D Detection Protocol
Research · INNODIA iVZW
Katholieke Universiteit Leuven, Leuven
Registry updated 2026-08-24
NCT05777330
Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes
Trial Treatment · Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Antwerpen, Antwerp · A.Z. Sint-Jan Brugge, Bruges · Universitair Ziekenhuis Gent, Ghent · Universitair Ziekenhuis Brussel, Jette · Universitair Ziekenhuis Leuven, Leuven · Clinique CHC MontLégia, Liège
Registry updated 2026-08-17
NCT06904846
To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period
Trial Treatment · Sinocare
UZA ANTWERP UZA Dienst Endocrinologie, Antwerp
Registry updated 2026-01-14
NCT07297342
A Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using the Standard Versus a More Intensified and Interactive Version of the "Get Ready" Smartphone Application.
Trial Treatment · Sint Dimpna Ziekenhuis Geel
Sint Dimpna ziekenhuis, Geel
Registry updated 2025-12-22
NCT06452654
Anti-viral Action Against Type 1 Diabetes Autoimmunity
Trial Treatment · Phase 4 · Technical University of Munich
University Hospitals Leuven, Faculty of Medicine, Catholic University of Leuven, Leuven
Registry updated 2025-09-23
NCT06445361
Prevalence of NAFLD in T1DM Patients
Trial Treatment · Ziekenhuis Oost-Limburg
Ziekenhuis Oost-Limburg, Genk
Registry updated 2025-07-28
NCT06770621
Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes
Trial Treatment · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Clinique Universitaires Saint-Luc, Brussels
Registry updated 2025-01-13
NCT05713448
Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes
Research · Universitaire Ziekenhuizen KU Leuven
Departement Endocrinology, University Hospitals Leuven, Leuven
Registry updated 2024-07-01

All Type 1 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error